Teijin Limited

The University of Arizona

Toru Sugano

Yasuhiko Masuho

Yoh-Ichi Matsumoto

Evan M Hersh

Takashi Kawamura

Eskild A Petersen

Douglas Lake

Satoshi Sasaki

Tsuyoshi Kimura

Katsuhiko Tomibe

Shigeki Fujinaga

Yohichi Matsumoto

Yoh-ichi Matsumoto

Eskild A Peterson

Takami Tomiyama

Human monoclonal antibodies which belong to the IgGl subclass and are specific for HIV are described. The monoclonal antibodies have potential for use in the diagnosis, prevention and therapy of HIV infection.

Monoclonal antibodies specific for HIV and the hybridomas for production

Human monoclonal antibodies which belong to the IgG1 subclass and are specific for HIV are described. The monoclonal antibodies have potential for use in the diagnosis, prevention and therapy of HIV infection.

The human monoclonal antibody to the glycoprotein gpIII of varicella zoster virus (VZV), and hybridoma producing same, are provided. The hybridoma is obtained by immunizing human lymphocytes with gpIII antigen in the presence of a mitogen, and selecting a monoclonal antibody which reacts with a cell monolayer ELISA plate but substantially does not react with a cell homogenate ELISA plate.

Human monoclonal antibody to glycoprotein GPIII of varicella zoster virus

Human IgG1 monoclonal antibodies are produced by hybridoma ATCC HB10074 and bind to gp120 of HIV.

Monoclonal antibodies specific for HIV and hybridomas for their

The invention is directed to the human hybridoma designated MCA 86 and having A.T.C.C. Accession No. HB 9669 and human monoclonal antibodies produced by hybridoma MCA 86. Human monoclonal antibodies produced by hybridoma MCA 86 immunologically binds to both gp41 and gp120 envelope glycoproteins of Human Immunodeficiency Virus (HIV). These monoclonal antibodies are useful in the diagnosis of HIV infection.

Human hybridomas and monoclonal antibodies which bind both gp41 and

Human monoclonal antibodies against cytomegalovirus. These antibodies can be advantageously used as a diagnostic, or preventive and remedy for cytomegalovirus infectious diseases.

Growing community of inventors

Tokyo, Japan

Toru Sugano